Review of Opsoclonus-Myoclonus Ataxia Syndrome in Pediatric Patients.
IVIG
Kinsbourne syndrome
dancing eye dancing feet syndrome
neuroblastoma
opsoclonus-myoclonus ataxia syndrome
paraneoplastic syndrome
pediatric
rituximab
Journal
Children (Basel, Switzerland)
ISSN: 2227-9067
Titre abrégé: Children (Basel)
Pays: Switzerland
ID NLM: 101648936
Informations de publication
Date de publication:
19 Mar 2024
19 Mar 2024
Historique:
received:
24
01
2024
revised:
10
03
2024
accepted:
18
03
2024
medline:
28
3
2024
pubmed:
28
3
2024
entrez:
28
3
2024
Statut:
epublish
Résumé
Opsoclonus-myoclonus ataxia syndrome (OMAS), also known as Kinsbourne syndrome, is a rare disorder that presents with myoclonus, ataxia, abnormal eye movements, irritability, and sleep disruptions, often in young children. We report a case of an infant barely 6 months old, with no significant past medical history, who presented to the emergency department with tremors, jerking motions of the head and arms, and rapid eye movements. After an extensive workup, she was found to have a neuroblastoma, which was subsequently surgically removed via thoracotomy. Despite an initial improvement in symptoms post-resection, the patient's symptoms recurred. She was subsequently treated with dexamethasone, intravenous immunoglobulin (IVIG), and rituximab. After treatment, the patient was noted to have mild global developmental delays but was otherwise well. This case report highlights the rare occurrence of OMAS in an infant barely 6 months old at diagnosis. Using the PubMed database, a systematic review was conducted to highlight the clinical presentation, diagnosis, and management of OMAS.
Identifiants
pubmed: 38539402
pii: children11030367
doi: 10.3390/children11030367
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng